Investigating BB0405 as a novel Borrelia afzelii vaccination candidate in Lyme borreliosis
Abstract BB0405 is a surface exposed Borrelia burgdorferi protein and its vaccination protected mice against B. burgdorferi infection. As BB0405 is highly conserved across different B. burgdorferi sensu lato species, we investigated whether vaccination with recombinant BB0405 or through intradermal...
Main Authors: | M. J. Klouwens, J. J. Trentelman, J. I. Ersoz, F. Nieves Marques Porto, R. Sima, O. Hajdusek, M. Thakur, U. Pal, J. W. Hovius |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-84130-y |
Similar Items
-
Systemic immune responses in patients with early localized or early disseminated Borrelia afzelii lyme borreliosis
by: Tjaša Cerar Kišek, et al.
Published: (2021-06-01) -
Evaluation of Borrelia burgdorferi BbHtrA Protease as a Vaccine Candidate for Lyme Borreliosis in Mice.
by: Amy J Ullmann, et al.
Published: (2015-01-01) -
Lyme Borreliosis and Borrelia spielmanii
by: Vera Maraspin, et al.
Published: (2006-07-01) -
Identification of Tick Ixodes ricinus Midgut Genes Differentially Expressed During the Transmission of Borrelia afzelii Spirochetes Using a Transcriptomic Approach
by: Sazzad Mahmood, et al.
Published: (2021-02-01) -
No evidence of Borrelia mayonii in an endemic area for Lyme borreliosis in France
by: Pierre H. Boyer, et al.
Published: (2017-06-01)